Reversal of diabetes through gene therapy of diabetic rats by hepatic insulin expression via lentiviral transduction

Molecular Therapy

Volumn 20, Issue 5, 2012, Pages 918-926

  Elsner, Matthias ^a   Terbish, Taivankhuu ^a   Jörns, Anne ^a   Naujok, Ortwin ^a   Wedekind, Dirk ^a   Hedrich, Hans Jürgen ^a   Lenzen, Sigurd ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; LENTIVIRUS VECTOR; PROINSULIN; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; DOSE RESPONSE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; IMMUNOFLUORESCENCE TEST; INSULIN RELEASE; LIVER STRUCTURE; LOW DRUG DOSE; NONHUMAN; RAT; SOMATIC GENE THERAPY; STREPTOZOCIN DIABETES; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ANIMALIA; LENTIVIRUS; RATTUS;

EID: 84860530730     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2012.8     Document Type: Article

References (37)

1. Paty, BW, Ryan, EA, Shapiro, AM, Lakey, JR and Robertson, RP (2002). Intrahepatic islet transplantation in type 1 diabetic patients does not restore hypoglycemic hormonal counterregulation or symptom recognition after insulin independence. Diabetes 51: 3428-3434. (Pubitemid 35403446)
2. Bailey, CJ, Davies, EL and Docherty, K (1999). Prospects for insulin delivery by ex-vivo somatic cell gene therapy. J Mol Med 77: 244-249. (Pubitemid 29146227)
3. Calne, RY, Gan, SU and Lee, KO (2010). Stem cell and gene therapies for diabetes mellitus. Nat Rev Endocrinol 6: 173-177.
4. Naujok, O, Burns, C, Jones, PM and Lenzen, S (2011). Insulin-producing surrogate ß-cells from embryonic stem cells: are we there yet? Mol Ther 19: 1759-1768.
5. Dong, H, Morral, N, McEvoy, R, Meseck, M, Thung, SN and Woo, SL (2001). Hepatic insulin expression improves glycemic control in type 1 diabetic rats. Diabetes Res Clin Pract 52: 153-163. (Pubitemid 32385327)
6. Olson, DE, Paveglio, SA, Huey, PU, Porter, MH and Thulé, PM (2003). Glucoseresponsive hepatic insulin gene therapy of spontaneously diabetic BB/Wor rats. Hum Gene Ther 14: 1401-1413. (Pubitemid 37268219)
7. Shaw, JA, Delday, MI, Hart, AW, Docherty, HM, Maltin, CA and Docherty, K (2002). Secretion of bioactive human insulin following plasmid-mediated gene transfer to non-neuroendocrine cell lines, primary cultures and rat skeletal muscle in vivo. J Endocrinol 172: 653-672. (Pubitemid 34232707)
8. Park, YM, Woo, S, Lee, GT, Ko, JY, Lee, Y, Zhao, ZS et al. (2005). Safety and efficacy of adeno-associated viral vector-mediated insulin gene transfer via portal vein to the livers of streptozotocin-induced diabetic Sprague-Dawley rats. J Gene Med 7: 621-629. (Pubitemid 40744528)
9. Dong, H, Altomonte, J, Morral, N, Meseck, M, Thung, SN and Woo, SL (2002). Basal insulin gene expression significantly improves conventional insulin therapy in type 1 diabetic rats. Diabetes 51: 130-138. (Pubitemid 34517989)
10. Auricchio, A, Gao, GP, Yu, QC, Raper, S, Rivera, VM, Clackson, T et al. (2002). Constitutive and regulated expression of processed insulin following in vivo hepatic gene transfer. Gene Ther 9: 963-971. (Pubitemid 34812287)
11. Mas, A, Montané, J, Anguela, XM, Muñoz, S, Douar, AM, Riu, E et al. (2006). Reversal of type 1 diabetes by engineering a glucose sensor in skeletal muscle. Diabetes 55: 1546-1553. (Pubitemid 44324106)
12. Ren, B, O'Brien, BA, Swan, MA, Koina, ME, Nassif, N, Wei, MQ et al. (2007). Long-term correction of diabetes in rats after lentiviral hepatic insulin gene therapy. Diabetologia 50: 1910-1920. (Pubitemid 47222846)
13. Zufferey, R, Dull, T, Mandel, RJ, Bukovsky, A, Quiroz, D, Naldini, L et al. (1998). Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 72: 9873-9880. (Pubitemid 28520853)
14. Groskreutz, DJ, Sliwkowski, MX and Gorman, CM (1994). Genetically engineered proinsulin constitutively processed and secreted as mature, active insulin. J Biol Chem 269: 6241-6245. (Pubitemid 24243015)
15. Sastry, L, Johnson, T, Hobson, MJ, Smucker, B and Cornetta, K (2002). Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods. Gene Ther 9: 1155-1162. (Pubitemid 34993938)
16. Warnock, JN, Daigre, C and Al-Rubeai, M (2011). Introduction to viral vectors. Methods Mol Biol 737: 1-25.
17. Kafri, T, Blömer, U, Peterson, DA, Gage, FH and Verma, IM (1997). Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat Genet 17: 314-317. (Pubitemid 27475995)
18. Park, F, Ohashi, K, Chiu, W, Naldini, L and Kay, MA (2000). Efficient lentiviral transduction of liver requires cell cycling in vivo. Nat Genet 24: 49-52. (Pubitemid 30041419)
19. Dull, T, Zufferey, R, Kelly, M, Mandel, RJ, Nguyen, M, Trono, D et al. (1998). A third-generation lentivirus vector with a conditional packaging system. J Virol 72: 8463-8471. (Pubitemid 28471781)
20. Park, F and Kay, MA (2001). Modified HIV-1 based lentiviral vectors have an effect on viral transduction efficiency and gene expression in vitro and in vivo. Mol Ther 4: 164-173. (Pubitemid 32851279)
21. Zufferey, R, Donello, JE, Trono, D and Hope, TJ (1999). Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J Virol 73: 2886-2892. (Pubitemid 29135675)
22. Demarchi, F, Gutierrez, MI and Giacca, M (1999). Human immunodeficiency virus type 1 tat protein activates transcription factor NF-kappaB through the cellular interferon-inducible, double-stranded RNA-dependent protein kinase, PKR. J Virol 73: 7080-7086. (Pubitemid 29327899)
23. Maggirwar, SB, Tong, N, Ramirez, S, Gelbard, HA and Dewhurst, S (1999). HIV-1 Tatmediated activation of glycogen synthase kinase-3beta contributes to Tat-mediated neurotoxicity. J Neurochem 73: 578-586. (Pubitemid 29339830)
24. Pavelka, M and Roth, J (2010). Functional Ultrastructure. Springer: Vienna. pp. 140-141.
25. Pauwels, K, Gijsbers, R, Toelen, J, Schambach, A, Willard-Gallo, K, Verheust, C et al. (2009). State-of-the-art lentiviral vectors for research use: risk assessment and biosafety recommendations. Curr Gene Ther 9: 459-474.
26. Lenzen, S (2008). Oxidative stress: the vulnerable beta-cell. Biochem Soc Trans 36(Pt 3): 343-347.
27. Lenzen, S, Tiedge, M, Elsner, M, Lortz, S, Weiss, H, Jörns, A et al. (2001). The LEW.1AR1/Ztm-iddm rat: a new model of spontaneous insulin-dependent diabetes mellitus. Diabetologia 44: 1189-1196. (Pubitemid 32835513)
28. Jörns, A, Günther, A, Hedrich, HJ, Wedekind, D, Tiedge, M and Lenzen, S (2005). Immune cell infiltration, cytokine expression, and beta-cell apoptosis during the development of type 1 diabetes in the spontaneously diabetic LEW.1AR1/Ztm-iddm rat. Diabetes 54: 2041-2052. (Pubitemid 40911267)
29. Arndt, T, Wedekind, D, Weiss, H, Tiedge, M, Lenzen, S, Hedrich, HJ et al. (2009). Prevention of spontaneous immune-mediated diabetes development in the LEW.1AR1-iddm rat by selective CD8+ T cell transfer is associated with a cytokine shift in the pancreas-draining lymph nodes. Diabetologia 52: 1381-1390.
30. Jörns, A, Rath, KJ, Terbish, T, Arndt, T, Meyer Zu Vilsendorf, A, Wedekind, D et al. (2010). Diabetes prevention by immunomodulatory FTY720 treatment in the LEW.1AR1-iddm rat despite immune cell activation. Endocrinology 151: 3555-3565.
31. Bolli, GB (2006). Insulin treatment in type 1 diabetes. Endocr Pract 12 (suppl. 1): 105-109. (Pubitemid 44963623)
32. Pickup, JC and Williams, G, (eds). (2003). Textbook of Diabetes. Blackwell Science Ltd: Oxford. pp. 43.1-43.5.
33. Sutherland, DE, Gruessner, AC, Carlson, AM, Blondet, JJ, Balamurugan, AN, Reigstad, KF et al. (2008). Islet autotransplant outcomes after total pancreatectomy: a contrast to islet allograft outcomes. Transplantation 86: 1799-1802.
34. Fiorina, P, Shapiro, AM, Ricordi, C and Secchi, A (2008). The clinical impact of islet transplantation. Am J Transplant 8: 1990-1997.
35. Burkhardt, BR, Parker, MJ, Zhang, YC, Song, S, Wasserfall, CH and Atkinson, MA (2005). Glucose transporter-2 (GLUT2) promoter mediated transgenic insulin production reduces hyperglycemia in diabetic mice. FEBS Lett 579: 5759-5764. (Pubitemid 41455660)
36. Hsu, PY, Kotin, RM and Yang, YW (2008). Glucose-and metabolically regulated hepatic insulin gene therapy for diabetes. Pharm Res 25: 1460-1468.
37. Picard, V, Ersdal-Badju, E, Lu, A and Bock, SC (1994). A rapid and efficient one-tube PCR-based mutagenesis technique using Pfu DNA polymerase. Nucleic Acids Res 22: 2587-2591. (Pubitemid 24222437)